1. Home
  2. CORT vs CDP Comparison

CORT vs CDP Comparison

Compare CORT & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$44.01

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo COPT Defense Properties of Beneficial Interest

CDP

COPT Defense Properties of Beneficial Interest

HOLD

Current Price

$30.60

Market Cap

3.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
CDP
Founded
1998
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CORT
CDP
Price
$44.01
$30.60
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$114.20
$32.86
AVG Volume (30 Days)
3.3M
1.1M
Earning Date
02-25-2026
02-05-2026
Dividend Yield
N/A
3.98%
EPS Growth
N/A
9.45
EPS
0.87
1.32
Revenue
$741,172,000.00
$752,757,000.00
Revenue This Year
$21.70
N/A
Revenue Next Year
$30.13
$4.39
P/E Ratio
$50.35
$23.19
Revenue Growth
17.92
0.43
52 Week Low
$32.99
$23.92
52 Week High
$117.33
$31.24

Technical Indicators

Market Signals
Indicator
CORT
CDP
Relative Strength Index (RSI) 40.15 65.47
Support Level $34.06 $30.06
Resistance Level $37.48 $30.89
Average True Range (ATR) 2.03 0.68
MACD 1.33 0.19
Stochastic Oscillator 94.99 92.30

Price Performance

Historical Comparison
CORT
CDP

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

Share on Social Networks: